245 related articles for article (PubMed ID: 30628067)
1. Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3.
Ahmmed B; Kampo S; Khan M; Faqeer A; Kumar SP; Yulin L; Liu JW; Yan Q
J Cell Physiol; 2019 Jul; 234(7):10680-10697. PubMed ID: 30628067
[TBL] [Abstract][Full Text] [Related]
2. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.
Arora S; Bhardwaj A; Singh S; Srivastava SK; McClellan S; Nirodi CS; Piazza GA; Grizzle WE; Owen LB; Singh AP
J Biol Chem; 2013 Jul; 288(29):21197-21207. PubMed ID: 23740244
[TBL] [Abstract][Full Text] [Related]
3. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer.
Li Y; Song X; Niu J; Ren M; Tang G; Sun Z; Kong F
Arch Biochem Biophys; 2021 Apr; 701():108818. PubMed ID: 33617838
[TBL] [Abstract][Full Text] [Related]
4. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
5. Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-κB signaling pathway.
Ahmmed B; Khan MN; Nisar MA; Kampo S; Zheng Q; Li Y; Yan Q
Int J Oncol; 2019 Feb; 54(2):431-442. PubMed ID: 30483742
[TBL] [Abstract][Full Text] [Related]
6. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
Ni J; Zhou S; Yuan W; Cen F; Yan Q
J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
[No Abstract] [Full Text] [Related]
8. Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB.
Tsubaki M; Takeda T; Tomonari Y; Koumoto YI; Imano M; Satou T; Nishida S
Lab Invest; 2019 Jan; 99(1):72-84. PubMed ID: 30353128
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxia-inducible factor 1 alpha and nuclear factor-kappa B signals.
Liu T; Zhao L; Hou H; Ding L; Chen W; Li X
Tumour Biol; 2017 May; 39(5):1010428317692225. PubMed ID: 28459376
[TBL] [Abstract][Full Text] [Related]
10. Putative Role of Nuclear Factor-Kappa B But Not Hypoxia-Inducible Factor-1α in Hypoxia-Dependent Regulation of Oxidative Stress in Hematopoietic Stem and Progenitor Cells.
Halvarsson C; Rörby E; Eliasson P; Lang S; Soneji S; Jönsson JI
Antioxid Redox Signal; 2019 Jul; 31(3):211-226. PubMed ID: 30827134
[No Abstract] [Full Text] [Related]
11. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
Yu Y; Wang J; Xia N; Li B; Jiang X
Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells.
He X; Wang J; Wei W; Shi M; Xin B; Zhang T; Shen X
Cancer Biol Ther; 2016; 17(2):188-98. PubMed ID: 26785721
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
Tafani M; Schito L; Pellegrini L; Villanova L; Marfe G; Anwar T; Rosa R; Indelicato M; Fini M; Pucci B; Russo MA
Carcinogenesis; 2011 Aug; 32(8):1167-75. PubMed ID: 21642357
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine resistance in non-small cell lung cancer is mediated through activation of the PI3K/AKT/NF-κB pathway and suppression of ERK signaling by reactive oxygen species.
Chiu CH; Lin YJ; Ramesh S; Kuo WW; Chen MC; Kuo CH; Li CC; Wang TF; Lin YM; Liao PH; Huang CY
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23497. PubMed ID: 37564025
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
Zhang Z; Duan Q; Zhao H; Liu T; Wu H; Shen Q; Wang C; Yin T
Cancer Lett; 2016 Nov; 382(1):53-63. PubMed ID: 27576197
[TBL] [Abstract][Full Text] [Related]
17. Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma.
Sharma V; Dixit D; Koul N; Mehta VS; Sen E
J Mol Med (Berl); 2011 Feb; 89(2):123-36. PubMed ID: 20865400
[TBL] [Abstract][Full Text] [Related]
18. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
Yang N; Liang Y; Yang P; Ji F
Oncol Rep; 2017 May; 37(5):2611-2619. PubMed ID: 28426124
[TBL] [Abstract][Full Text] [Related]
19. Involvement of HIF-1α-regulated miR-21, acting via the Akt/NF-κB pathway, in malignant transformation of HBE cells induced by cigarette smoke extract.
Lu L; Xu H; Yang P; Xue J; Chen C; Sun Q; Yang Q; Lu J; Shi A; Liu Q
Toxicol Lett; 2018 Jun; 289():14-21. PubMed ID: 29501572
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.
Hu FQ; Qiao T; Xie X; Hu R; Xiao HB
J Biol Regul Homeost Agents; 2014; 28(4):649-57. PubMed ID: 25620175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]